The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_213599.3(ANO5):c.751C>T (p.Pro251Ser)

CA379920329

1488412 (ClinVar)

Gene: ANO5 (HGNC:203859)
Condition: autosomal recessive limb-girdle muscular dystrophy (MONDO:0015152)
Inheritance Mode: Autosomal recessive inheritance
UUID: a4849de3-cf27-4d8d-b704-f2b9d0780db7
Approved on: 2026-03-13
Published on: 2026-04-10

HGVS expressions

NM_213599.3(ANO5):c.751C>T (p.Pro251Ser)
NM_213599.3:c.751C>T
NC_000011.10:g.22236265C>T
CM000673.2:g.22236265C>T
NC_000011.9:g.22257811C>T
CM000673.1:g.22257811C>T
NC_000011.8:g.22214387C>T
NG_015844.1:g.48090C>T
ENST00000682266.1:c.301C>T
ENST00000682341.1:c.709C>T
ENST00000682530.1:c.*683C>T
ENST00000682684.1:n.1130C>T
ENST00000683197.1:c.709C>T
ENST00000683411.1:c.301C>T
ENST00000683437.1:c.301C>T
ENST00000683613.1:n.1745C>T
ENST00000683834.1:n.951C>T
ENST00000684663.1:c.706C>T
ENST00000324559.9:c.751C>T
ENST00000648804.1:n.1213+8679C>T
ENST00000324559.8:c.751C>T
NM_001142649.1:c.748C>T
NM_213599.2:c.751C>T
NM_001142649.2:c.748C>T
More

Uncertain Significance

Met criteria codes 4
PM3_Supporting PM2_Supporting PP4 PP3
Not Met criteria codes 1
PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ANO5 Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_213599.3: c.751G>T variant in ANO5 is a missense variant expected to cause the substitution of proline with serine at position 251, p.(Pro251Ser). This variant has been reported in one individual with a clinical suspicion of LGMD, where it was identified in unconfirmed phase with a pathogenic variant (c.108_109del p.(Glu36AspfsTer7), 0.5 pts, PMID: 37688281) (PM3_Supporting, PP4). This variant is absent from gnomAD v4.1.0 in a region with good sequencing coverage (PM2_Supporting). The computational predictor REVEL gives a score of 0.75, which exceeds the VCEP threshold of ≥0.70, evidence that correlates with impact to ANO5 function (PP3). In summary, there is currently insufficient evidence to classify this variant as pathogenic or benign, and it remains a variant of uncertain significance for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 2.0.0; 03/13/2026): PM3_Supporting, PP4, PM2_Supporting, PP3.
Met criteria codes
PM3_Supporting
This variant has been reported in one individual with a clinical suspicion of LGMD, where it was identified in unconfirmed phase with a pathogenic variant (c.108_109del p.(Glu36AspfsTer7), 0.5 pts, PMID: 37688281) (PM3_Supporting). ClinVar: VUS by Revvity (SCV003826762.3) - this almost certainly reflects the Nallamilli (2023)/GRASP case included above VUS by LabCorp (formerly Invitae) (SCV002274573.4, last evaluated April 2024) not in LOVD no additional literature identified To upgrade to LP, PM3 would need to reach _Strong, meaning 1.5 more PM3 pts are needed. It seems extremely unlikely that LabCorp (formerly Invitae) would have multiple cases, particularly with a VUS classification in 2024, and so we chose not to reach out for their internal data at this time.
PM2_Supporting
This variant is absent from gnomAD v4.1.0 in a region with good sequencing coverage (PM2_Supporting).
PP4
This variant has been identified in a heterozygous state with a second presumed diagnostic ANO5 variant in one individual with a clinical suspicion of LGMD (PMID: 37688281; PP4).
PP3
The computational predictor REVEL gives a score of 0.75, which exceeds the VCEP threshold of ≥0.70, evidence that correlates with impact to ANO5 function (PP3). highest masked SpliceAI delta score: 0.11
Not Met criteria codes
PM5
c.752C>T p.(Pro251Leu) has been reported (PMID: 35563815 - unconfirmed phase with c.41-1G>A, which is P by the VCEP). However, that appears to be the only literature report, and the variant is not in LOVD or ClinVar, suggesting it will not reach an LP classification (PP3, PM2_Supporting, PM3_Supporting, PP4).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.